NY Oncology Hematology PC- Latham- Capital District Oncology Hematology — Latham, New York

NY Oncology Hematology PC- Latham- Capital District Oncology Hematology is a clinical research site located in Latham, New York, United States 12110.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

NY Oncology Hematology PC- Latham- Capital District Oncology Hematology has participated in 1 clinical trials.

Therapeutic areas: Breast Cancer.

Sponsors: NSABP Foundation Inc.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Latham

Browse all research sites in New York · View every site in Latham

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for NY Oncology Hematology PC- Latham- Capital District Oncology Hematology?

NY Oncology Hematology PC- Latham- Capital District Oncology Hematology has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has NY Oncology Hematology PC- Latham- Capital District Oncology Hematology conducted?

NY Oncology Hematology PC- Latham- Capital District Oncology Hematology has 1 clinical trials on record. Their work covers Breast Cancer.

Is NY Oncology Hematology PC- Latham- Capital District Oncology Hematology accredited by Crixeo Clinical Trials?

NY Oncology Hematology PC- Latham- Capital District Oncology Hematology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about NY Oncology Hematology PC- Latham- Capital District Oncology Hematology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.